Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 24 Issue 8, August 2018

Oncogenic control of stress response

In this issue, Iannis Aifantis and colleagues report that the oncogenic NOTCH1 controls activation of the heat-shock response in T cell acute lymphoblastic leukemia, and they uncover potential biomarkers of response to HSP90 inhibition. The cover art is a reproduction of ‘The Heat Factor’ (Despina Stokou, 2018; oil, markers, charcoal and collage on canvas). Text from the manuscript was incorporated in the artwork.

See Aifantis and colleagues

Image: Despina Stokou. Cover Design: Erin Dewalt.

Editorial

  • Concerns about potential unintended DNA changes that might accidentally arise from CRISPR gene editing have emerged to varying degrees with the advent of the technology. As new therapies move from bench to bedside, scientists need to redouble their efforts to document the spectrum of these off-target effects while also acknowledging the reality that a certain degree of risk is embedded in many promising and successful medical therapies.

    Editorial

    Advertisement

Top of page ⤴

News Feature

  • Period-tracking apps offer new insights on women’s health.

    • Shraddha Chakradhar
    News Feature
  • Researchers hope the Veterans Affairs’ research agenda won’t change much if it integrates more private care.

    • Katharine Gammon
    News Feature
Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • The human heart contains two macrophage populations with distinct self-maintenance and inflammatory functions. A shift in the balance between these macrophage populations correlates with left-ventricle remodeling and systolic function in patients with heart failure.

    • Freya R. Svedberg
    • Martin Guilliams
    News & Views
  • Targeting senescent cells with repurposed FDA-approved drugs improves phenotypes of aging in mice.

    • Manuel Serrano
    • Nir Barzilai
    News & Views
  • Intratumoral infusion of a nonpathogenic replication-competent recombinant polio-rhinovirus chimera (PVSRIPO) for recurrent glioblastoma demonstrates safety and promising preliminary treatment responses.

    • J. Bryan Iorgulescu
    • David A. Reardon
    • Catherine J. Wu
    News & Views
Top of page ⤴

Perspectives

Top of page ⤴

Brief Communications

Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Resources

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links